Optimal 99mTc radiolabeling and uptake of glucosamine sulfate by cartilage. A potential tracer for scintigraphic detection of osteoarthritis

Bioconjugate Chemistry

Volumn 20, Issue 8, 2009, Pages 1547-1552

  Sobal, Grazyna ^a   Menzel, Johannes ^b   Sinzinger, Helmut ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSAMINE; NUCLEAR MEDICINE; SULFUR COMPOUNDS; TIN;

RADIOLABELLING; SATURATION TIME; SULFATE CONTENT; SULPHATES;

CARTILAGE;

GLUCOSAMINE SULFATE; TECHNETIUM 99M; TIN; TRACER; DIAGNOSTIC AGENT; GLUCOSAMINE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM;

ADULT; AGED; ARTICLE; CARTILAGE DEGENERATION; CASE REPORT; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MONITORING; DRUG STABILITY; DRUG UPTAKE; FEMALE; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; MALE; OSTEOARTHRITIS; PH; RIB CARTILAGE; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THERAPY EFFECT; CARTILAGE; CHEMISTRY; METABOLISM; MIDDLE AGED; RIB; SCINTISCANNING; TISSUE DISTRIBUTION;

AGED; CARTILAGE; GLUCOSAMINE; HUMANS; HYDROGEN-ION CONCENTRATION; ISOTOPE LABELING; MALE; MIDDLE AGED; OSTEOARTHRITIS; RADIOPHARMACEUTICALS; RIBS; TECHNETIUM; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 70349085395     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc9000883     Document Type: Article

References (35)

1. Baker, C. L., Jr., and Ferguson, C. M. (2005) Future treatment of osteoarthritis. Orthopedics 28, 227-234.
2. Fajardo, M., and Di Cesare, P. E. (2005) Disease-modifying therapies for osteoarthritis: current status. Drugs Aging 22, 141-161. (Pubitemid 40445324)
3. Palmieri, L., Conte, A., Giovannini, L., Lualdi, P., and Ronca, G. (1990) Metabolic fate of exogenous chondroitin sulfate in the experimental animal. Arzneimittelforsch. Drug Res. 40, 319-323. (Pubitemid 20103617)
4. Ronca, F., Palmieri, L., Pinicucci, P., and Ronca, G. (1998) Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage 6S A, 14-21.
5. Chan, P. S., Caron, J. P., Rosa, G. J., and Orth, M. W. (2005) Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants. Osteoarthritis Cartilage 13, 387-394.
6. Trattnig, S., Ba-Ssalamah, A., Puig, S., and Imhof, H. (2000) Magnetic resonance imaging of articular cartilage and evaluation of cartilage disease. Invest. Radiol. 35, 595-601. (Pubitemid 30758077)
7. Hanly, J. G., Mitchell, M. J., Barnes, D. C., and MacMillan, L. (1994) Early recognition of sacroiliitis by magnetic resonance imaging and single photon emission computed tomography. J. Rheumatol. 21, 2088-2095. (Pubitemid 24352357)
8. 99mTc et scintigraphie du cartilage. Isotopes Radioactivite Clin. Recherch. 12, 183-191.
9. Palmer, W. E., Schoenberg, O. I., Fischman, A. J., Rosenthall, D. I., and Polisson, R. P. (1994) FDG metabolism in the wrist during treatment of inflammatory arthritis: Quantitation with PET and correlation with clinical response (abstr.). J. Nucl. Med. 35, 45P.
10. Sobal, G., Menzel, E. J., and Sinzinger, H. (2008) Radiolabeling procedure, quality control and stability of 99mTc-labeled chondroitin sulfate: A new approach of targeting osteoarthritis. Appl. Radiat. Isotopes 66, 415-420.
11. Elson, L. A., and Morgan, W. T. (1933) A colorimetric method for the determination of glucosamine and chondrosamine. Biochem. J. 27, 1824-1828.
12. Hamerman, D. (1989) The biology of osteoarthritis. N. Engl. J. Med. 320, 1322-1330.
13. Lequesne, M., Brandt, K., Bellamy, N., Moskowitz, R., Menkes, C. J., Pelletier, J. P., and Altman, R. (1994) Guidelines for testing slow acting drugs in osteoarthritis. J. Rheumatol. 21, 65-73. (Pubitemid 24285541)
14. Piperno, M., Hellio Le Graverand, M. P., Conrozier, T., Bochu, M., Mathieu, P., and Vignon, E. (1998) Quantitative evaluation of joint space width infemorotibial osteoarthritis: comparison of three radiographic views. Osteoarthritis Cartilage 6, 252-259. (Pubitemid 28341739)
15. Mazzuca, S. A., Brandt, K. D., and Katz, B. P. (1997) Is conventional radiography suitable for evaluation of a disease-modifying drug in patients with knee osteoarthritis? Osteoarthritis Cartilage 5, 217-226.
16. Crolle, G., and D'Este, E. (1980) Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation. Curr. Med. Res. Opin. 7, 104-109. (Pubitemid 11161037)
17. Reichelt, A., Forster, K. K., Fischer, M., Rovati, L. C., and Setnikar, I. (1994) Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomised, placebo-controlled, double-blind study. Arzneimittelforschung 44, 75-80. (Pubitemid 24036884)
18. Thie, N. M., Prasad, N. G., and Major, P. W. (2001) Evaluation of glucosamine sulfate compared to ibuprofen for the treatment of temporomandibular joint osteoarthritis: a randomized double blind controlled 3 month clinical trial. J Rheumatol. 28, 1347-1355.
19. Qiu, G. X., Gao, S. N., Giacovelli, G., Rovati, L., and Setnikar, I. (1998) Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis. Arzneimittelforschung 48, 469-474. (Pubitemid 28247632)
20. Setnikar, I., Cereda, R., Pacini, M. A., and Revel, L. (1991) Antireactive properties of glucosamine sulfate. Arzneimittelforschung 41, 157-161.
21. Shikhman, A. R., Kuhn, K., Alaaeddine, N., and Lotz, M. (2001) N-acetylglucosamine prevents IL-1 beta-mediated activation of human chondrocytes. J. Immunol. 166, 5155-5160. (Pubitemid 32280730)
22. Rovati, L. C. (1997) The clinical profile of glucosamine sulfate as a selective symptom modifying drug in and osteoarthritis: current data and perspectives. Osteoarthritis Cartilage 5 (supplA), 72.
23. Bassleer, C., Rovati, L., and Franchimont, P. (1998) Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage 6, 427-434. (Pubitemid 28529800)
24. Dodge, G. R., Hawkins, D., Boesler, E., Sakai, L., and Jimenez, S. A. (1998) Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts. Osteoarthritis Cartilage 6, 435-440. (Pubitemid 28529801)
25. Sandy, J. D., Thompson, V., Verscharen, C., and Gamett, D. (1999) Chondrocyte-mediated catabolism of aggrecan: evidence for a glycosylphosphatidylinositol-linked protein in the aggrecanase response to interleukin-1 or retinoic acid. Arch. Biochem. Biophys. 367, 258-264. (Pubitemid 29394173)
26. Noack, W., Fischer, M., Forster, K. K., Rovati, L. C., and Setnikar, I. (1994) Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage 2, 51-59.
27. Muller-Fassbender, H., Bach, G. L., Haase, W., Rovati, L. C., and Setnikar, I. (1999) Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage 2, 61-69.
28. McAlindon, T. E., LaValley, M. P., Gulin, J. P., and Felson, D. T. (1999) Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 283, 1469-1475.
29. Hardingham, T. E., and Fosang, A. J. (1992) Proteoglycans: many forms and many functions. FASEB J. 6, 861-870.
30. de los Reyes, G. C., Koda, R. T., and Lien, E. J. (2000) Glucosamine and chondroitin sulfates in the treatment of osteoarthritis: a survey. Prog. Drug Res. 55, 81-103.
31. Verbruggen, G., Goemaere, S., and Veys, E. (1998) Chondroitin sulfate: S/DMOAD (structure/disease modifying antiosteoarthritis drug) in the treatment of finger joint OA. Osteoarthritis Cartilage 6, 37-38. (Pubitemid 28255103)
32. Setnikar, I., Giacchetti, C., and Zanolo, G. (1986) Pharmacokinetics of glucosamine in the dog and in man. Arzneimittelforschung 36, 729-735.
33. Setnikar, I., Giacchetti, C., and Zanolo, G. (1984) Absorption, distribution and excretion of radioactivity after a single intravenous or oral administration of [14C] glucosamine to the rat. Pharmatherapeutica 3, 538-550. (Pubitemid 14176468)
34. Fosang, A. J., and Little, C. B. (2008) Drug insight: aggrecanases as therapeutic targets for osteoarthritis. Clin. Pract. Rheumatol. 4, 420-427.
35. Wang, L., and Detamore, M. S. (2009) Effects of growth factors and glucosamine on porcine mandibular condylar cartilage cells and hyaline cartilage cells for tissue engineering applications. Arch. Oral. Biol. 54, 1-5.